74 related articles for article (PubMed ID: 2177366)
21. The role of insulin antibodies in insulin treatment of type I diabetes.
Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
Exp Clin Endocrinol; 1986 Jun; 87(1):79-88. PubMed ID: 3527726
[TBL] [Abstract][Full Text] [Related]
22. Insulin antibodies--do they matter?
Walford S
Neth J Med; 1985; 28 Suppl 1():47-9. PubMed ID: 3892339
[No Abstract] [Full Text] [Related]
23. Immunologic implications of insulin delivery and the role of immune complexes in diabetic sequelae.
Charles MA; Ong K; Slater L; Golden M; Arquilla ER
Diabetes Care; 1982; 5 Suppl 1():88-92. PubMed ID: 6765123
[TBL] [Abstract][Full Text] [Related]
24. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
[TBL] [Abstract][Full Text] [Related]
25. Studies on the different forms of material reacting with antiinsulin antibodies in the fetal and adult rat.
Felix JM; Sutter-Dub MT; Legrele C
Horm Metab Res; 1975 Sep; 7(5):394-9. PubMed ID: 1183918
[TBL] [Abstract][Full Text] [Related]
26. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
[TBL] [Abstract][Full Text] [Related]
27. [Plasma insulin-binding capacity of diabetes mellitus patients with labile and stable courses].
Alekseev IuP; Kliachko VP
Probl Endokrinol (Mosk); 1975; 21(6):7-10. PubMed ID: 1232999
[TBL] [Abstract][Full Text] [Related]
28. [Immunologic response to insulin therapy].
Saccarello A; De Micheli A; Boeri D; Maiello M
Clin Ter; 1982 Aug; 102(3):293-308. PubMed ID: 6183045
[No Abstract] [Full Text] [Related]
29. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
[TBL] [Abstract][Full Text] [Related]
30. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
31. Insulin antibodies and the control of diabetes.
Dixon K; Exon PD; Malins JM
Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
[TBL] [Abstract][Full Text] [Related]
32. [Cooperative effects during interaction of monoclonal antibodies with insulin dimers].
Rubtsova MIu; Cherednikova TV; Susova MB; Gavrilova EM; Egorov AM
Biokhimiia; 1987 Sep; 52(9):1531-8. PubMed ID: 3315010
[TBL] [Abstract][Full Text] [Related]
33. Idiotypic and fluorometric analysis of the antibodies that distinguish the lesion of the I-A mutant B6.C-H-2bm12.
Melino MR; Epstein SL; Sachs DH; Hansen TH
J Immunol; 1983 Jul; 131(1):359-64. PubMed ID: 6190915
[TBL] [Abstract][Full Text] [Related]
34. Insulin--binding antibodies in Nigerian diabetic patients.
Bella AF; Adetuyibi A
West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207
[TBL] [Abstract][Full Text] [Related]
35. Correlations between insulin antibodies and the HLA system in a group of type I diabetic patients in Bucharest.
Ionescu-Tîrgovişte C; Cheţa D; Truia CI; Truia M; Mirodon Z; Ilinca D; Cheţa N; Mincu I
Med Interne; 1986; 24(1):11-7. PubMed ID: 3704498
[TBL] [Abstract][Full Text] [Related]
36. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
Bemm H; Lohmann D
Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
[TBL] [Abstract][Full Text] [Related]
37. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.
Maruyama T; Takei I; Yanagawa T; Takahashi T; Asaba Y; Kataoka K; Ishii T
Diabetes Res; 1988 Feb; 7(2):93-6. PubMed ID: 3293880
[TBL] [Abstract][Full Text] [Related]
38. [Determination of binding constants of antibodies fractionated according to their affinity to insulin].
Karulin AIu; Dikov MM; Egorov AM
Biokhimiia; 1986 May; 51(5):746-50. PubMed ID: 3518815
[TBL] [Abstract][Full Text] [Related]
39. [Anti-insulin antibodies and circulating immune complexes in patients with diabetes mellitus].
Efimov AS; Malyzhev VA; Sakalo EA
Ter Arkh; 1987; 59(11):15-8. PubMed ID: 3441859
[TBL] [Abstract][Full Text] [Related]
40. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
